Where does Seoul National University Hospital rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Seoul National University Hospital ranks #5,883 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Seoul National University Hospital hold?

Seoul National University Hospital holds 58 US utility patents granted between 2015 and 2025, spanning 33 technology areas.

What is Seoul National University Hospital's Innovation Score?

Seoul National University Hospital has an Innovation Score of 49.3 out of 100 (top 15% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Seoul National University Hospital focus on?

Seoul National University Hospital's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 17 patents, ranking #1,046 of 7,127 assignees active in that subclass. Grants appear in 33 CPC subclasses total.

Is Seoul National University Hospital's patent grant rate increasing or decreasing?

Seoul National University Hospital's recent grant velocity is +550% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Seoul National University Hospital's patents?

Seoul National University Hospital's patents average 8.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Seoul National University Hospital patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Seoul National University Hospital

USPTO PatentsView assignee record - 58 granted patents across 33 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Seoul ranks #5,883 of 49,997 tracked US assignees by granted-patent volume, with 58 patents across 33 technology areas.

#5,883
of 49,997 US assignees by volume: Top 15%
by Innovation Score (49.3/100): 8.6
avg claims per patent: +550%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5883 · Foreign Corporation #5,883 · 58 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 58 grants
UPPER-Q #5,883/49,997
PHOTO-FINISH Real Value
CPC-FOCUS A61B · 33 areas
INNOV-PAR 49.3/100
CLAIMS-PAR 8.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +550% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Real Value LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Seoul’s 49.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.1 pts (29%) Velocity 9.8 pts (20%) Breadth 20.3 pts (41%) Claim depth 5.1 pts (10%)

Qualcomm Incorporated · highest

85
Nissin Electric · near

49
Seereal · near

49
Seoul National… · this assignee

49
Swiss Krono Tec · near

49
Woodwelding · near

49
3D Lighting… · lowest

7

What this shows Seoul's Innovation Score is 49.3/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Seoul?

Each dot is one of Seoul’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Seoul’s own 8.6 claims/patent is ABOVE the 7.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Seoul vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Seoul's grants concentrate

Seoul National University Hospital is a focused PatentsView assignee: 33 CPC subclasses with 29.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (10 grants) versus a trough of 1 in 2018. By volume, Seoul sits between Real Value LLC and Safran Seats.

Seoul's three-year grant acceleration

Seoul National University Hospital shows 25 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Real Value

58
Riverpoint Medical

58
Sakata INX

58
Sami Labs

58
Soft Robotics

58
Solarflare Commun…

58
Sorel

58
Safran Seats

58
Seoul National Un… ◀

58

What this shows Seoul holds 58 patents at rank #5,880, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Seoul

By rank, the assignees closest to #5,880 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Seoul's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Seoul, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Seoul ranks #1,046 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Seereal Technologies S.A. 49 Woodwelding AG 49 Swiss Krono Tec AG 49 Nissin Electric Co., Ltd. 49

Similar claim depth

Nearest assignees by average claims per patent (8.6 here).

TPR Co., Ltd. 8.6 avg Solystic 8.6 avg Tmeic Corporation 8.6 avg Ambit Microsystems (SHANGHAI) Ltd. 8.6 avg

Seoul's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Seoul National University Hospital patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	3.4%
2018	1	1.7%
2019	3	5.2%
2020	10	17.2%
2021	4	6.9%
2022	10	17.2%
2023	8	13.8%
2024	7	12.1%
2025partial year	13	22.4%

Which technologies does Seoul National University Hospital patent most?

A61B - DIAGNOSIS; SURGERY; Identification 17

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 14

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 14

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 9

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

G06T - Image Data Processing OR Generation, IN General 8

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 7

C07D - Heterocyclic Compounds 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 4

G06V - Image OR Video Recognition OR Understanding 4

G06F - Electric Digital Data Processing 4

Y02A - Technologies FOR Adaptation TO Climate Change 4

C07K - Peptides 4

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

Top 15 of 33 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Seoul National University Hospital's patent record in context - here's where to go next.

Seoul National University Hospital's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 29.3% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #5,883 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Seoul National University Hospital against Real Value LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.